Prophylactic low-dose heparin by jet injection
Subcutaneous low-dose heparin is a popular and effective method of prevention of postoperative thromboembolism.5 2 Complications include pain and bruising at injection sites, wound haematomas, and occasionally serious bleeding due to accidental overdosage.3 Little attention, however, has been paid to the increased nursing work load in giving multiple injections, and this may lead to missed doses. As the prophylactic dose of heparin is standard (5000 IU) we thought that a multidose jet injector might be employed. Jet injection has been used successfully for mass inoculation4 and for giving insulin6 and was known to be rapid and accurate.
Patients, methods, and results
A lightweight hand-held injcctor was used (Med-e-Jet, System Micro-jet). The drug phial fixes to a detachable, autoclavable head and fluid is ejected at high velocity through a 0 15-mm orifice. Power is provided by a small disposable carbon dioxide cylinder. If cylinder pressure drops below 21 kg/cm2 (300 lb in2) a spring device prevents firing and precludes inadequate penetration when the cylinder nears exhaustion. About 25 shots are obtained from a 16-g cylinder. Injection pressure and dose volume are adjustable. With heparin of 25 000 IU/ml strength, dose volume was 0 2 ml. The actual volume delivered was found to be accurate and reproducible. By in-vitro dye injection experiments a pressure setting was found at which the entire 0 2-ml dose was deposited into subcutaneous tissue throughout the life of the gas cylinder.
Injections were made into flat skin cleaned with alcohol. The flank proved a suitable site, avoiding striae gravidarum in women, and both nurses and patients found jet injection acceptable: it was less painful than needle injection and bruising was no more frequent. Thirteen volunteers received 5000 units of sodium heparin by jet injection. Mean Jet injection is a closed system and contamination is unlikely. In addition, multidose phials of heparin contain antiseptic, so it was not thought necessary to autoclave injection heads whenever the phial was changed. Regular bacterial cultures were taken from empty phials and of ejected heparin. No organisms were isolated. As the injection head makes contact with different patients, contamination with blood or tissue fluid during injection might theoretically lead to spread of hepatitis B if used on a carrier. Multiple injections were therefore made in vitro, into tissue infiltrated with radioactive isotope. No increased radioactivity was found on the injection heads. In the demonstrated absence of contamination with blood or tissue fluid, the risk of spreading hepatitis appears remote.
Jet injection incurs an initial capital cost, but thereafter operation is economical because no heparin is wasted in priming syringes. The capital cost would be amortised in a short time on most surgical wards.
Comment
Jet injection offers several advantages over traditional methods of giving prophylactic low-dose heparin, provided that it is as effective in preventing thromboembolism. Studies to investigate this are in progress. 
Leg ulcers, both venous and arterial, have been reported in patients with Klinefelter's syndrome. Vogt and Breit' described three patients in whom arterial insufficiency was considered a-major cause of the ulcers and Palou et al2 reported two similar cases. Zuppinger et al3 found varicose veins in eight of 24 patients with Klinefelter's syndrome, four of whom had leg ulcers. Thomsen4 described four patients attending a dermatology clinic, two of whom had hypostatic ulcers. Federman5 recorded varicose veins in eight of 24 patients, three having hypostatic ulcers.
Other conditions, particularly chronic bronchitis and emphysema and diabetes, seem to be common in these patients. The incidence of Klinefelter's syndrome is possibly 1 in 400 male live births. The statistics of hypostatic ulcers are very uncertain, perhaps 0-2-055% of the population being affected, with a female preponderance of 2-4:1. Peripheral vascular disease, both venous and arterial, appears to be common in Klinefelter's syndrome and should be considered in men presenting with chronic leg ulcers.
I am grateful to Dr R E Bowers, for information about cases 5 and 6. The blood pressure may be controlled rapidly in severe hypertension by giving intravenous labetalol (Trandate), which is effective within minutes. Three out of 16 patients treated in this way complained of faintness and sweating from the prompt fall in blood pressure.' To prevent this tendency a constant infusion technique has been developed, which gradually reduces blood pressure over several hours of careful adjustment of infusion rate and incremental dose against recorded blood pressure levels.' The complexity of this regimen makes it unsuitable for use in a general medical ward, and we have used oral labetalol, which is effective within two hours,3 to achieve satisfactory control of blood pressure in hypertensive emergencies. The initial 24-hour period of treatment with oral labetalol in severe hypertension.
The simplicity of oral administration has obvious advantages, providing a promising alternative to parenteral treatment, which requires intensive care monitoring. Labetalol, a combined beta-and alpha-receptor blocking drug, produces good reduction in blood pressure with a first dose of 400 mg or 300 mg in severe hypertension, with a smooth and gradual effect over hours. Sustained control over the first 24 hours occurred without mishap. In this small series the rare pressor response4 was not observed, but a careful watch for complications should be kept at all times.
